Data Collection for CAD Evaluation
Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · May 14, 2012
Trial Information
Current as of May 29, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Data Collection for CAD Evaluation," is focused on gathering information from mammograms to improve the way we evaluate breast health using a software called VUCOMp. The goal is to better understand how this software can help in detecting breast conditions by analyzing raw data from digital mammography images.
The trial is currently recruiting female participants who have undergone digital mammography. Unfortunately, men are not eligible to participate. If you qualify and choose to join, you can expect to provide mammogram images that will be used for research purposes. This study is important because it aims to enhance breast cancer detection methods, ultimately helping to improve care for women in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • women who underwent a digital mammography imaging
- Exclusion Criteria:
- • men
About Universitaire Ziekenhuizen Ku Leuven
Universitaire Ziekenhuizen KU Leuven is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. Affiliated with KU Leuven, one of Europe’s premier universities, the institution integrates cutting-edge scientific inquiry with high-quality patient care. It plays a pivotal role in the development and implementation of clinical trials, fostering collaboration between researchers, healthcare professionals, and industry partners to translate scientific discoveries into effective treatments. The hospital's multidisciplinary approach ensures comprehensive patient safety and ethical standards, positioning it as a trusted sponsor in the realm of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leuven, , Belgium
Patients applied
Trial Officials
Chantal Van Ongeval, MR,Phd
Principal Investigator
Universitaire Ziekenhuizen KU Leuven
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials